- Home
- CRIS vs AXDX Comparison
CRIS vs AXDX Comparison
Compare CRIS & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- AXDX
- Stock Information
- Founded
- CRIS 2000
- AXDX 1982
- Country
- CRIS United States
- AXDX United States
- Employees
- CRIS N/A
- AXDX N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- CRIS Health Care
- AXDX Industrials
- Exchange
- CRIS Nasdaq
- AXDX Nasdaq
- Market Cap
- CRIS 32.8M
- AXDX 27.5M
- IPO Year
- CRIS 2000
- AXDX 1996
- Fundamental
- Price
- CRIS $3.29
- AXDX $1.07
- Analyst Decision
- CRIS Strong Buy
- AXDX Hold
- Analyst Count
- CRIS 3
- AXDX 1
- Target Price
- CRIS $23.00
- AXDX $1.00
- AVG Volume (30 Days)
- CRIS 243.3K
- AXDX 74.2K
- Earning Date
- CRIS 02-06-2025
- AXDX 11-07-2024
- Dividend Yield
- CRIS N/A
- AXDX N/A
- EPS Growth
- CRIS N/A
- AXDX N/A
- EPS
- CRIS N/A
- AXDX N/A
- Revenue
- CRIS $10,259,000.00
- AXDX $11,909,000.00
- Revenue This Year
- CRIS N/A
- AXDX $0.66
- Revenue Next Year
- CRIS N/A
- AXDX $3.44
- P/E Ratio
- CRIS N/A
- AXDX N/A
- Revenue Growth
- CRIS 0.44
- AXDX N/A
- 52 Week Low
- CRIS $2.86
- AXDX $0.73
- 52 Week High
- CRIS $17.49
- AXDX $2.09
- Technical
- Relative Strength Index (RSI)
- CRIS 44.97
- AXDX 37.88
- Support Level
- CRIS $3.10
- AXDX $1.07
- Resistance Level
- CRIS $3.60
- AXDX $1.17
- Average True Range (ATR)
- CRIS 0.37
- AXDX 0.11
- MACD
- CRIS 0.00
- AXDX 0.01
- Stochastic Oscillator
- CRIS 26.22
- AXDX 20.51
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.